Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hitoshi Masuda
Institutions:
National Cancer Center Hospital East,
National Cancer Center Hospital
Observed institutions:
The Cancer Institute Hospital,
National Cancer Center Hospital East,
National Cancer Center Hospital
ORCID:
0000-0002-9182-8481
Observed ORCID:
0000-0002-9182-8481
OpenAlex ID:
A5057359054
[A comparative study assessing clinical effects of naftopidil and tamsulosin hydrochloride on benign prostatic hyperplasia].
2002
·
Tetsuo Hayashi
, Yasuyuki Sakai
, et al.
·
PubMed
·
12
PDF
Time-Dependent Comparative Effectiveness of First-Line Treatment for Metastatic Clear Cell Renal Cell Carcinoma: A Restricted Mean Survival Time-Based Network Meta-analysis
2026
·
Hiroshi Fukushima
, Shugo Yajima
, et al.
·
Targeted Oncology
·
7
Re-evaluating Treatments for Advanced Urothelial Carcinoma Using Restricted Mean Survival Time: A Systematic Review and Network Meta-analysis
2026
·
Shugo Yajima
, Wei Chen
, et al.
·
European Urology Open Science
·
6
Delayed Survival Benefit of Enzalutamide Plus Radium‐223 in Metastatic Castration‐Resistant Prostate Cancer: A Time‐Dependent Analysis of Reconstructed Individual Patient Data From the PEACE ‐3 Trial
2026
·
Wei Chen
, Soichiro Yoshida
, et al.
·
International Journal of Urology
·
4
PDF
Single, early intravesical instillation of pirarubicin in the prevention of bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403): a multicentre, open-label, randomised, phase 3 trial
2026
·
Akihiro Ito
, Yoichi Arai
, et al.
·
The Lancet Oncology
·
3
Prognostic Value of Inflammatory Biomarkers as Continuous Variables in Metastatic Renal Cell Carcinoma: Linearity Assessment, Proportional Hazards Assumption Testing, and Time‐Varying Effects
2026
·
Shugo Yajima
, Soichiro Yoshida
, et al.
·
International Journal of Urology
·
3
The Japanese Version of the National Institutes of Health Chronic Prostatitis Symptom Index
2014
·
Satoshi Takahashi
, Koichiro Wada
, et al.
·
The Japanese Journal of Urology
·
3
PDF
Quantitative Assessment of Additive Effects of Mirabegron and Solifenacin in Overactive Bladder: Re-analysis of SYNERGY Study
2026
·
Wei Chen
, Soichiro Yoshida
, et al.
·
Urology
·
2
Mixture cure model analysis of event-free survival in the NIAGARA Trial: Quantifying the cure fraction benefit of perioperative durvalumab in muscle-invasive bladder cancer
2026
·
Shugo Yajima
, Soichiro Yoshida
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
2
Bayesian Multi‐Criteria Decision Analysis of Net Clinical Benefit in ARASENS : Overall and Japanese Subgroup Results
2026
·
Kenji Tanabe
, Soichiro Yoshida
, et al.
·
International Journal of Urology
·
2
PDF
Pharmacologic synergy versus independent action in androgen receptor-axis-targeted agent-docetaxel triplet therapy for metastatic hormone-sensitive prostate cancer: a copula-based analysis
2026
·
Wei Chen
, Soichiro Yoshida
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
2
Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysis
2026
·
Shugo Yajima
, Soichiro Yoshida
, et al.
·
Japanese Journal of Clinical Oncology
·
2
Probabilistic multi-criteria decision analysis comparing robot-assisted and laparoscopic radical nephroureterectomy
2026
·
Shugo Yajima
, Soichiro Yoshida
, et al.
·
Journal of Robotic Surgery
·
2
Time-varying prognostic value of circulating tumor DNA in urothelial carcinoma: A systematic review and reconstructed patient-data meta-analysis
2026
·
Shugo Yajima
, Gaku Okumura
, et al.
·
Critical Reviews in Oncology/Hematology
·
1
Enfortumab vedotin monotherapy, enfortumab vedotin plus pembrolizumab, and immune checkpoint inhibitor-based neoadjuvant therapy for muscle-invasive bladder cancer: A systematic review and meta-analysis
2026
·
Shugo Yajima
, Soichiro Yoshida
, et al.
·
Urologic Oncology Seminars and Original Investigations
·
1
Exploratory Time‐Dependent Patterns in Estimated Treatment Effect of Talazoparib Plus Enzalutamide in HRR Non‐Deficient or Unknown Metastatic Castration‐Resistant Prostate Cancer: A Post Hoc Analysis of the TALAPRO ‐2 Trial
2026
·
Shugo Yajima
, Soichiro Yoshida
, et al.
·
International Journal of Urology
·
1
Circulating tumor DNA as a prognostic biomarker in adjuvant nivolumab therapy for high-risk muscle-invasive urothelial carcinoma: insights from CheckMate 274 and beyond
2026
·
Shugo Yajima
, Hitoshi Masuda
·
Translational Andrology and Urology
·
1
Comparison of Perioperative Chemotherapy Regimens for Muscle‐Invasive Bladder Cancer: A Reconstructed Individual Patient Data Analysis of Phase 3 Trials
2026
·
Shugo Yajima
, Soichiro Yoshida
, et al.
·
International Journal of Urology
·
1
Robot‐Assisted Kidney‐Sparing Surgery for Distal Ureteral Urothelial Carcinoma: Initial Experience With Five Cases in Japan
2025
·
Shugo Yajima
, Gaku Okumura
, et al.
·
Asian Journal of Endoscopic Surgery
·
1
PDF
Experience of Ileal Neobladder for Bladder Cancer by Hautmann Procedure
1994
·
Takumi Yamada
, Hitoshi Masuda
, et al.
·
The Japanese Journal of Urology
·
1
PDF
Analysis of Continence Mechanisms by Stress Urethral Pressure Profiles
1994
·
Hitoshi Masuda
, Takumi Yamada
, et al.
·
The Japanese Journal of Urology
·
1
PDF
Adrenal metastasectomy for oligometastatic non–small cell lung cancer in the era of immunotherapy and molecular-targeted therapy: outcomes and application of the ESTRO-EORTC oligometastatic classification in a single-institution surgical cohort
2026
·
Tomoki Kimura
, Shugo Yajima
, et al.
·
Research Square
PDF
Adjuvant Systemic Therapies After Nephrectomy for Renal Cell Carcinoma: A Bayesian Network Meta-Analysis and Multi-Criteria Benefit–Risk Assessment
2026
·
Shugo Yajima
, Gaku Okumura
, et al.
·
Targeted Oncology
Time-dependent effects of BCG plus immune checkpoint inhibitors in BCG-naive high-risk non-muscle-invasive bladder cancer: a reconstructed patient-level analysis
2026
·
Shugo Yajima
, Soichiro Yoshida
, et al.
·
International Urology and Nephrology
Nerve-sparing radical cystectomy in the era of perioperative enfortumab vedotin plus pembrolizumab: reappraising the value of functional preservation
2026
·
Shugo Yajima
, Hitoshi Masuda
·
Translational Andrology and Urology
Show more works
View as search
Works count:
48
Citation count:
58
H-index:
4
I10-index:
1
Year
Topic
Type